RadNet Inc
Change company Symbol lookup
Select an option...
RDNT RadNet Inc
ASO Academy Sports & Outdoors Inc
AAPL Apple Inc
RJF Raymond James Financial Inc
BHP BHP Group Ltd
COPX Global X Copper Miners ETF
QOEG Quality Online Education Group Inc
VCVCU 10X Capital Venture Acquisition Corp
JRJC China Finance Online Co Ltd
CRM Salesforce.Com Inc
Go

Health Care : Health Care Providers & Services | Small Cap Blend
Company profile

RadNet, Inc. is a provider of freestanding, fixed-site outpatient diagnostic imaging services in the United States. As of December 31, 2016, the Company operated directly or indirectly through joint ventures, 305 centers located in California, Delaware, Florida, Maryland, New Jersey, New York and Rhode Island. Its centers provide physicians with imaging capabilities to facilitate the diagnosis and treatment of diseases and disorders. Its services include magnetic resonance imaging (MRI), computed tomography (CT), positron emission tomography (PET), nuclear medicine, mammography, ultrasound, diagnostic radiology (X-ray), fluoroscopy and other related procedures. As of December 31, 2016, the Company had in operation 257 MRI systems, 157 CT systems, 47 PET or combination PET/CT systems, 48 nuclear medicine systems, 479 X-ray systems, 279 mammography systems, 551 ultrasound systems and 104 fluoroscopy systems.

Postmarket

Last Trade
Delayed
$33.12
0.00 (0.00%)
Bid
--
Ask
--
B/A Size
--

Market Hours

Closing Price
$33.12
Day's Change
1.83 (5.85%)
Bid close
--
Ask close
--
B/A Size
--
Day's High
33.22
Day's Low
31.45
Volume
(Average)
Volume:
362,968

10-day average volume:
334,047
362,968

Company Profile

RadNet, Inc. is a provider of freestanding, fixed-site outpatient diagnostic imaging services in the United States. As of December 31, 2016, the Company operated directly or indirectly through joint ventures, 305 centers located in California, Delaware, Florida, Maryland, New Jersey, New York and Rhode Island. Its centers provide physicians with imaging capabilities to facilitate the diagnosis and treatment of diseases and disorders. Its services include magnetic resonance imaging (MRI), computed tomography (CT), positron emission tomography (PET), nuclear medicine, mammography, ultrasound, diagnostic radiology (X-ray), fluoroscopy and other related procedures. As of December 31, 2016, the Company had in operation 257 MRI systems, 157 CT systems, 47 PET or combination PET/CT systems, 48 nuclear medicine systems, 479 X-ray systems, 279 mammography systems, 551 ultrasound systems and 104 fluoroscopy systems.

Valuation Ratios

Price/Earnings (TTM)
152.18x
Price/Sales (TTM)
1.49x
Price/Book (MRQ)
8.88x
Price/Cash Flow (TTM)
14.51x
TTM = Trailing Twelve Months
MRQ = Most Recent Quarter

Price Performance

Historic Growth and Share Detail

Historic Growth

Annual growth, past 5 years
EPS
Revenue
Dividend No Regular Dividend is paid
 

Short Interest

May 2021
Current Month
1.1M
Previous Month
1.1M
Percent of Float
2.44%
Days to Cover
6.9680 Days

Share Information

RDNT is in a share class of common stock
Float
45.1M
Shares Outstanding
52.7M
Institutions Holding Shares
201
66.15%

Financial Statements

Balance sheet

Values displayed are in millions.

Income statement

Values displayed are in millions.

Cash flow

Values displayed are in thousands.

Company Officers

  • Howard G. BergerChmn.
  • Mark D. StolperCFO
  • Stephen M. ForthuberCorp.Exec.
  • Norman R. HamesCorp.Exec.
  • Mital Patel

Address

Insider Trading

During the most recent quarter, 13K shares were bought, and 211K shares were sold in insider trading.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Insider trading information report provided by Copyright © 2021. All rights reserved.

Reuters content is the intellectual property of Reuters. Any copying, republication or redistribution of Reuters content, including by caching, framing or similar means, is expressly prohibited without the prior written consent of Reuters. Reuters is not liable for any errors or delays in content, or for any actions taken in reliance on any content. Reuters, Reuters Logo and the Sphere Logo are trademarks and registered trademarks of the Reuters Group of companies around the world.

Data is provided for information purposes only and is not intended for trading purposes. Reuters shall not be liable for any errors or delay in the content, or for any action taken in reliance on any content. The RIC or Reuters Instrument Code set has been developed and maintained by Reuters and is the intellectual property of Reuters.